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Summary
A 43 x 103 Afr protein (designated connexin 43 or Cx43)
is a major constituent of heart gap junctions. The
understanding of its arrangement in junctional mem-
branes has been extended by means of site-directed
antibodies raised against synthetic peptides of Cx43.
These represent part of the first extracellular loop
(EL-46), the cytoplasmic loop (CL-100), the second
extracellular loop (EL-186) and carboxy-terminal se-
quences (CT-237 and CT-360). All of the antibodies
raised reacted with their respective peptides and the
Cx43 protein on Western blots. By immunoelectron
microscopy two of the antibodies (CL-100 and CT-
360) were shown to label the cytoplasmic surface of
isolated gap junction membranes. Immunofluor-
escent labeling at locations of neonatal cardiac
myocyte-myocyte apposition required an alkali/
urea treatment when the EL-46 and EL-186 anti-
bodies were used. Immunoblot analysis of endopro-
teinase Lys-C-digested gap junctions revealed that
the Cx43 protein passed through the lipid bilayer
four times. Alkaline phosphatase digestion of iso-
lated junctions was used to show that the CT-360
antibody recognized many phosphorylated forms of
Cx43. Our results unequivocally confirm models of
the organization of Cx43 that were based on a more
Limited set of data and a priori considerations of the
sequence.
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Introduction
Gap junctions provide the means for the passage of small
cytoplasmic molecules (e.g. inorganic ions, metabolites,
messengers) from one cell to another. They consist of
channels (connexons) that cross the membrane of one cell
and pair with connexons from another cell, thus forming a
pathway for direct cell-cell exchanges. Gap junctions are
commonly thought to play roles in cell growth and differ-
entiation (Warner et al. 1984; Revel, 1986; Gilula, 1987).
In cardiac tissue, gap junctions are also believed to be
involved in conductance of electric signals between cells,
resulting in the synchronous beating of the heart (Griepp
and Bernfield, 1978; De Haan et al. 1981; as reviewed by
Forbes and Sperelakis, 1985).
A wealth of information has identified a 43xlO3Mr
protein (connexin43 or Cx43) as a major constituent of gap
junctions in the heart (Manjunath et al. 1984a,6; Manju-
nath and Page, 1986; Beyer etal. 1987). Immunocyto-
chemical labeling studies have provided direct evidence
that Cx43 is found in gap junction membranes and that it
is also widely distributed in other tissues and vertebrate
species (Dupont et al. 1988; Beyer et al. 1989; Yancey et al.
1989). Evidence supporting a role for Cx43 in intercellular
communication has recently been provided by Swenson
etal. (1989), who showed elevated levels of gap junctional
coupling in Xenopus oocyte pairs injected with Cx43-
coding mRNA. The ability of several anti-connexin anti-
bodies to block dye coupling (Hertzberg et al. 1986; Yancey
et al. 1989) and electrical coupling (Hertzberg et al. 1985)
after intracellular injection into cardiac myocytes has
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provided further support for the junctional role of Cx43.
The rat Cx43 protein has been cloned (Beyer et al. 1987)
and shown to have high sequence homology to the rat
Cx32 (Paul, 1986) and Cx26 (Nicholson and Zhang, 1988;
Zhang and Nicholson, 1989) gap junction proteins, both of
which are found in the liver and other tissues.
The evidence adduced up to now suggests that the
polypeptide chain of the Cx43 protein threads through the
lipid bilayer four times with two loops exposed in the
extracellular gap. These extracellular loops are thought to
be responsible for the interactions between connexons in
apposed cell membranes. The amino and carboxy termini
are believed to be located in the cytoplasm (Manjunath
et al. 1987; Beyer et al. 1987). An amino-terminal-specinc,
anti-Cx43 antibody, was recently used to confirm the
cytoplasmic orientation of the N-terminal domain (Yancey
et al. 1989). The same authors also provided experimental
evidence for a cytoplasmic loop domain of approximately
4xlO3Mr in size. This is consistent with models of the
Cx32 protein, which is also believed to span the membrane
four times and to have a cytoplasmic loop region and the
carboxy terminus exposed to the cytoplasm (Zimmer et al.
1987; Hertzberg et al. 1988; Goodenough et al. 1988; Milks
et al. 1988).
As an extension of earlier work on the topology and
structure of Cx43 described above, five new site-directed
antibodies were successfully raised to two highly con-
served regions of the molecule predicted to represent the
extracellular loops (Beyer et al. 1987) and three cytoplas-
mic domains (Beyer et al. 1987; Yancey et al. 1989). We
have used proteolysis of the Cx43 protein in conjunction
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with immunoblotting techniques to provide direct evi-
dence that the polypeptide passes through the membrane
four times, yielding two extracellular loops and an anti-
body-accessible cytoplasmic loop. Furthermore, our
studies provide sharper constraints than available pre-
viously on what parts of the molecule could be in the
membrane.
Materials and methods
Peptide synthesis
Peptides corresponding to the amino acid residues 46-76,
100-122, 186-206, 237-259 and 360-382 of Cx43 heart gap
junction protein (Beyer etal. 1987) were synthesized on an
Applied Biosystems Peptide synthesizer (Suzanna Horvath, Cal-
tech). The purity of each peptide was determined by high perform-
ance liquid chromatography (HPLC). Four of the peptides (46-76,
100-122,186-206 and 237-259) were synthesized with a cysteine
added on at the carboxy terminus and one peptide (360-382) had a
cysteine added on at the amino terminus. Approximately 12 mg of
the reduced 237-269 and 360-382 peptides were conjugated
through the carboxy and amino cysteines, respectively, to 10 mg
of keyhole limpet hemocyanin (KLH) using succinimidyl-4-(iV-
maleimidomethyl) cyclohexane-1-carboxylate (Pierce Chemical
Co., Rockford, IL) as a cross-linking reagent. Samples of the
conjugated peptides were stored at -80°C for future immuniz-
ations.
Production of site-directed polyclonal antibodies
Prior to the immunization of rabbits for antibody production,
10-20 ml of preimmune serum was collected from each rabbit and
immediately stored at -80°C for future use. Approximately 2mg
of free peptide (46-76, 100-122, 186-206) or 2.5 mg of KLH-
conjugated peptide (237-259, 360-382) was dissolved in 2 ml of
phosphate-buffered saline (PBS), pH7.4, and reconstituted in a
vial of adjuvant (Ribi, Hamilton, MT, Cat. no. R-730). The vial
was vortexed extensively and 1 ml of the emulsion was adminis-
tered to the rabbit by a series of intradermal, intramuscular and
subcutaneous injections. The immunized rabbits were boosted at
3-week intervals with 1 ml of the same antigen using an identical
injection protocol. Routinely, the serum from immunized rabbits
was collected 7, 11 and 14 days after each boost and stored at
-80°C.
Antibody binding assay
A solid-phase radioimmune assay (RIA) was used to determine
the ability of a rabbit immune serum to bind to immobilized
synthetic peptides. Approximately 30-50 ng of synthetic peptides
were immobilized in poly-L-lysine (average molecular weight
59000) coated, flexible, 96-well assay plates (Falcon, Lincoln
Park, NJ). The plates were quenched of non-specific binding sites
by incubating the wells in PBS containing 1 % BSA for 1 h. The
rabbit serum was serially diluted and 50 jil was added to each well
for l h at room temperature. After extensive washing in PBS,
antibody binding was detected by incubating the wells for 1 h in
12SI-labeled goat anti-rabbit IgG (lxlO8 to 2xl06disints//g~1)
antibody. After washing extensively in PBS, the radioimmune
assay was completed by counting the individual wells in a gamma
counter.
Antibody affinity purification
Site-directed antibodies were purified from rabbit sera according
to the following procedure. Approximately 2-3 mg of synthetic
peptide was dissolved in 0.7 ml of 0.5 M sodium carbonate buffer,
pH 9.3, and incubated with an aldehyde-activated MAC 25 mem-
brane filter (Memtec Corporation, Billerica, MA) overnight at
room temperature. The filter was quenched of any remaining
binding sites with 0.1% sodium borohydride in PBS for 30min
and subsequently washed sequentially with PBS, 1 M NaCl, 0.1 M
glycine, pH2.3, and PBS. Approximately 1-3 ml of rabbit im-
mune serum was passed through the filter several (10-15) times
to allow for specific antibody binding. After washing the filter
with 30-50 ml of PBS, bound antibody was eluted with 1-2 ml of
0 . 1 M glycine, pH2.3. The absorbance at 280 nm was measured
and the concentration of antibody was calculated using an
extinction coefficient (mg~1mlcm~ ) of 1.4. The pH of the sol-
ution containing the purified antibody was brought to neutrality
by dialysis against PBS.
Conjugation ofrhodamine to a purified site-directed
antibody
Briefly, 1.5ml (125/(gmT1) of affinity-purified CT-360 antibody
in 0 . 1 M sodium carbonate (pH9.0) containing 0.5% BSA was
combined with 50 ^g of dimethyl sulfoxide (DMSO) dissolved
tetramethylrhodamine isothiocyanate (Calbiochem Corporation,
San Diego, CA) and incubated at 4°C for 18 h. The conjugation
reaction was stopped by incubating the mixture for an additional
2 h at 4°C in the presence of 50 mM NH4CI. Finally, the unbound
dye was separated from the conjugate on a Biogel P-4 column as
described by Harlow and Lane (1988). The conjugate was stored in
the dark at 4°C for future immunofluorescent labeling studies.
Membrane preparations and proteolysis
Crude cardiac cell plasma membranes were prepared as described
by Manjunath et al. (1986). Gap junction plaques were isolated
from 300-350 g male Sprague-Dawley rat (Simonsen Labora-
tories, Gilroy, CA) hearts according to the method of Manjunath
and Page (1986). The purity of the gap-junctional membrane
preparations was assessed by SDS-PAGE in conjunction with
Coomassie Blue staining. Protein concentrations were estimated
by densitometry of Coomassie Blue-stained gels or by using BCA
protein assay reagent (Pierce Chemical Co.).
Isolated cardiac gap-junctional plaques were digested with
endoproteinase Lys-C (Boehringer-Mannheim Biochemicals,
Indianapolis, IN) according to Yancey etal. (1989). Completely
digested gap-junctional membranes were subjected to
SDS-PAGE and Western blotting for analysis by purified anti-
bodies.
Alkaline phosphatase digestion of isolated cardiac gap
junctions
Isolated cardiac gap junctions were incubated with alkaline
phosphatase from calf intestine (Boehringer-Mannheim Bio-
chemicals) (4-7 units fig"1 gap junction protein) at 37°C in 0 . 1 M
Tris buffer, pH 8.0. After 2 h the junctions were centrifuged in an
Eppendorf centrifuge for 15min to remove the free phosphate. In
order to ensure complete digestion, the gap junction pellet was
resuspended in alkaline phosphatase (4-7 units ^g"1 gap junction
protein) and incubated at 37°C for 14-16 h. The digested junctions
were washed, solubilized and immediately applied to a 10%
SDS-polyacrylamide gel.
SDS-polyacrylamide gel electrophoresis and Western
blotting
Gap junction membrane preparations were solubilized in an equal
volume of denaturing buffer containing 4 % SDS, 10 % 2-mercap-
toethanol, 0.01 % Bromophenol Blue and 60 mM Tris-HCl, pH 6.8.
Generally, 5-10 fd of sample was applied to the wells of a 12 %
SDS-polyacrylamide gel or a 10% SDS-polyacrylamide gel
containing 0.4% bisacrylamide and electrophoresis was carried
out at 15 mA using the buffer system of Laemmli (1970). Molecu-
lar weight standards obtained from Bio-Rad Laboratories (Cam-
bridge, MA) were as follows: myosin, 200000; phosphorylase B,
97400; bovine serum albumin, 66200; ovalbumin, 42 700; car-
bonic anhydrase, 31000; soybean trypsin inhibitor, 21500; and
lysozyme, 14400.
SDS-denatured proteins were transferred to nitrocellulose
paper by a semi-dry transfer method as described by Yancey et al.
(1989). Following transfer the nitrocellulose was quenched of any
remaining protein binding sites by incubation in a Tween 20
immunoblot buffer (0.15 M NaCl, 1 mM EDTA, 1 mM NaN3, 0.5 %
Tween 20 and 20 mM Tris-acetate, pH 7.4). All subsequent anti-
body dilutions and washes were done in immunoblot buffer
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containing 0.05% Tween 20. The quenched nitrocellulose blots
were treated with 0.2-1.5/igml"1 of purified site-directed anti-
bodies for 1 h at 23 °C. After extensive washing, antibody binding
was detected using goat anti-rabbit IgG conjugated to alkaline
phosphatase (Promega Biotec, Madison, WI). Finally, the blots
were washed and developed according to established procedures
using bromochloroindolyl phosphate/nitro blue tetrazolium sub-
strate (Harlow and Lane, 1988).
Immunogold labeling of cardiac gap junction membranes
Approximately 0.5-1.0 fig of a gap junction membrane prep-
aration was combined with 10-15 fig of a crude cardiac plasma
membrane preparation in PBS and incubated overnight at room
temperature in poly-L-lysine-coated 96-well plates. After rinsing
out the unbound membranes the wells were quenched for 1 h in
PBS containing 5% BSA. The immobilized membranes were
treated with a 25- to 100-fold dilution of preimmune or immune
serum for lh . Alternatively, the membranes were treated with
SO-llS/tgml"1 affinity-purified antibodies. After washing in
PBS, the wells were treated for 1 h with a 10-fold dilution of goat
anti-rabbit IgG antibody-conjugated to 5 nm gold particles (Jans-
sen Life Sciences, Piscataway, NJ). After washing as before in
PBS, the membranes were fixed with 2 % glutaraldehyde in 0.1 M
cacodylate buffer, pH 7.2, and prepared for electron microscopy as
described by Yancey et al. (1989). Thin sections were viewed
under a Philips 420 electron microscope.
Neonatal cardiac cell cultures
Primary cultures of neonatal rat heart myocytes were prepared
according to a modification of Burt (1982) and Yancey et al. (1989).
Hearts from one-day-old rats were dissected, minced and the cells
were dissociated by a series of 16min digests with 0.175%
pancreatin (Gibco Laboratories, Grand Island, NY) at 37 °C in
136mM NaCl, 2.6mM KC1, 0.3HIM NaH2PO4, 11.9DIM NaHCO3,
11.1 mM dextrose and 0.25 % Phenol Red, pH 7.2. Fully dissociated
cells were plated in Hank's balanced salt solution supplemented
with (GIBCO) lxMEM vitamins, lxMEM amino acids, lxMEM
non-essential amino acids, 2mM L-glutamine, 0.66 mM glycine,
0.9mM hypoxanthine, 9.8mM NaHCO3, 0.25% Phenol Red, 10%
fetal calf serum and antibiotics. Cardiac myocytes were separated
from more adhesive cells (fibroblasts) by plating the cells at 37 °C
for 60-90 min. The loosely attached myocytes were removed from
the plate by gentle aspiration and 2xlO6 to 8x10° cells ml"1 were
recultured in plastic dishes containing 12 mm glass coverslips.
Cell cultures were maintained for 1-6 days at 37 °C in an
environment of 5 % CO2 and 95 % air.
Immunofluorescent labeling studies
Myocytes grown on glass coverslips from 2- to 4-day-old cultures
were rinsed in PBS and fixed in absolute ethanol for 10-20 min at
room temperature. Alternatively, myocytes were fixed in 1 %
paraformaldehyde for 45-90 min at 4°C prior to washing in
several changes of PBS for 30-45 min. In some cases, fixed cells
were left at 4°C overnight in PBS and treated further with 10 mM
Tris, pH12.0, containing 8 M urea for l - 2 h at 30-37°C in an
attempt to split the gap junction membranes. All samples were
quenched of remaining non-specific binding sites by incubating in
PBS containing 2% BSA for 45 min. Quenched coverslips were
treated for l h with 2-20 fig ml"1 affinity-purified site-directed
antibodies diluted in quenching buffer. The cells were washed
extensively in PBS and incubated for 1 h with a 500-fold dilution
of a goat anti-rabbit IgG antibody conjugated to fluorescein
(Boehringer-Mannheim). After washing as before, the coverslips
were mounted in 90% glycerol containing 0.1 % paraphenylene-
diamine and 100 mM Tris, pH9.0.
In some cases, myocytes were labeled with culture fluid from an
anti-myosin hybridoma cell line followed by a goat anti-mouse
IgG antibody conjugated to rhodamine (Boehringer-Mannheim).
These same cells were subsequently labeled with an anti-Cx43
antibody as described above. In other double-labeling exper-
iments, permeabilized myocytes were indirectly treated with CL-
100 antibody in conjunction with a goat anti-rabbit IgG fluor-
escein conjugate and labeled with CT-360 antibody directly
conjugated to rhodamine. All cells were observed and photo-
graphed under a Zeiss phase-contrast microscope equipped for
epifluorescence.
Results
Characterization of site-directed antibodies
The rat cardiac Cx43 gap junction protein consists of a
single polypeptide chain of 382 amino acids (Beyer et al.
1987). Five peptide analogues to segments of this protein
have been synthesized, purified and injected into rabbits
for the production of site-directed antibodies. The peptide
sequence and the assigned name for each antibody are
shown in Table 1. The five peptides selected were predicted
to be part of segments believed to be exposed outside the
hydrophobic core of the Cx43 protein (Beyer et al. 1987;
Yancey et al. 1989) (Fig. 1). Thus, the 46-76 and 186-206
peptides have been postulated to represent portions of the
first and second extracellular loops, respectively, while the
100-122 peptide has been predicted to constitute part of
the cytoplasmic loop. The 237-259 and 360-382 peptides,
in turn, are believed to correspond to sequences located on
the proteolytically sensitive carboxy-terminal portion of
the molecule (Manjunath et al. 1985; Manjunath et al.
1987) (Fig. 1). The antibodies raised against these peptides
were used to study the structural arrangement of Cx43 in
gap junction membranes.
The crude serum collected from each immunized rabbit
was found to be 5- to 15-fold more reactive towards
immobilized peptides than the corresponding preimmune
serum (Table 1). Three of the site-directed antibodies (CL-
100, EL-186 and CT-360) were found to be highly reactive
towards the Cx43 protein on Western blots, at serum
dilutions of 5000-, 2000- and 20000-fold, respectively.
However, the reactivity of EL-46 and CT-237 antibodies to
Cx43 on Western blots was not as high. Although there
Table 1. Characterization of site-directed antibodies
Antibody
EL-46
CL-100
EL-186
CT-237
CT-360
Peptide
sequence
46-76
100-122
186-206
237-259
360-382
Reactivity to peptide
(ctsmin"1 immune serum
ctsmin" preimmune)
14.8
9.8
5.1
11.1
10.6
Relative reactivity
to peptide
Relative reactivity
to Cx43 in
immunoblots
The Cx43 peptides synthesized were based on the protein sequence obtained from Beyer et al. (1987). The prefixes used for the site-directed antibodies
indicate the location of the epitopes with respect to the lipid bilayer: EL, extracellular loop; CL, cytoplaflmic loop; and CT, carboxy terminus. The
number associated with each antibody denotes the amino acid closest to the amino terminus. Reactivity against the peptides was measured as binding
of the immune serum to immobilized synthetic peptides by a radioimmune assay In all cases the respective preimmune serum was assayed as a
measure of non-specific binding The relative ability of the antibodies to bind to the Cx43 protein was determined by SDS-PAGE in conjunction with
immunoblotting.
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Fig. 1. A model of Cx43 depicting the
locations of the peptide segments
synthesized (in bold) and the names of the
corresponding antibodies raised. This
model illustrating how the polypeptide
threads through the membrane four times,
yielding two extracellular loops and a
cytoplasmic loop was constructed based on
proposed models for Cx32 (Paul, 1986;
Zimmer et al. 1987; Milks et al. 1988;
Goodenough et al. 1988) and recent models
of Cx43 (Beyer et al. 1987; Yancey et al.
1989). The Cx43 peptides that we chose to
raise antibodies against represented two
highly conserved domains predicted to be
exposed to the extracellular surface and
three segments postulated to be accessible
to the cytoplasm (Beyer et al. 1987; Yancey
et al. 1989). The transmembrane helical
segments are denoted by roman numerals.
was considerable sequence homology between some of the
Cx43 peptides (46-76 and 186-206) and segments of the
Cx32 polypeptide chain, none of the antibodies raised
cross-reacted with Cx32 on Western blots (unpublished
data).
Site-directed antibodies were purified against virtually
homogeneous (as defined by HPLC) synthetic peptides by
passing immune serum through peptide-coated MAC 25
membrane filters. One antibody (CT-237) could not be
purified using this technique, suggesting that the immobi-
lized peptide did not present the proper conformation for
antibody binding.
Topology of Cx43
Proteolysis of cardiac gap junctions. Isolated cardiac
gap junctions were subjected to proteolysis and the result-
ing fragments were analyzed by immunoblotting. As
reported previously (Manjunath et al. 19846; Yancey et al.
1989), SDS-PAGE of heart gap junction membrane prep-
arations yielded a broad band at 43xlO3Afr as well as
three breakdown products of 35, 33 and 31xlO3Mr (Fig. 2,
CB lane a), which are believed to have lost carboxy-
terminal fragments (as shown below). The additional
bands above 43xlO3Afr represent either aggregates of
Cx43 or impurities in the gap junction membrane prep-
aration. Immunoblotting with affinity-purified CL-100,
EL-46 and EL-186 antibodies resulted in the labeling of
the major band at 43xlO3Afr and also the breakdown
products at 35, 33 and 31xlO3Mr (Fig. 2, CL, EL lane a).
In blots treated with purified CT-360 antibody (specific for
the C-tenninal tip) the 43xlO3Afr band, but not the
breakdown products, were labeled, indicating the loss of
carboxy-terminal domains in the bands seen at 35, 33 and
31xlOsAfr (Fig. 2, CT lane a).
When isolated junctions were completely digested with
endoproteinase Lys-C (which cleaves proteins at the car-
boxy side of lysine residues) a major membrane-bound
fragment was resolved at 15xlO3Mr and a second more
diffuse band at approximately 21xlO3Mr (Fig. 2, CB lane
b).
The EL-46 site-directed antibody labeled a band at
15xlO3Mr as well as some incompletely endoproteinase
Lys-C-digested or aggregated fragments at 28, 30 and
38xlO3Mr, but no bands around 21-22xlO3Mr (Fig. 2,
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Fig. 2. Analysis of polypeptides from untreated and endoproteinase Lys-C-digested gap junction membranes that bind site-directed
antibodies. Undigested gap junction membranes (lane a) or endoproteinase Lys-C-digested gap junction membranes (Jane b) were
washed and electrophoresed on a 12 % SDS-polyacrylamide gel. The polypeptides were either stained with Coomassie Blue (CB) or
transferred to nitrocellulose paper and treated with the affinity-purified site-directed antibodies indicated. The molecular weight
standards (described in Materials and methods) are shown in the far left lane of the Coomassie Blue-stained gel.
lane b). A similar, but weaker, pattern of labeling was
observed for the CL-100 antibody (Fig. 2, lane b). However,
the EL-186 antibody only labeled the broad 21xlO3Mr
fragment (Fig. 2, lane b). Endoproteinase Lys-C digestions
of isolated junctions resulted in the loss of CT-360 antibody
binding. These results suggest that the binding site for the
EL-46 and EL-186 antibodies are protected from endopro-
teinase Lys-C digestion but epitopes exposed on the cyto-
plasmic side are more easily accessed. The epitopes for EL-
46 and EL-186 antibodies were also retained when junc-
tional membranes were digested with trypsin (unpub-
lished data).
Immunogold labeling of isolated junctions. Immuno-
gold-labeling studies were performed in order to explore
further the accessibility of the various domains of the
Cx43 protein in gap junctions. Both the CT-360 and CL-
100 antibodies could be used to immunogold label the
cytoplasmic surface of isolated junctions (Fig. 3A,B).
When preimmune sera were used only a few scattered gold
particles were observed along the membrane surface
(Fig. 3C). The EL-186 antibody was shown to be virtually
ineffective in immunogold labeling of gap junction mem-
brane preparations (Fig- 3D). In several instances, how-
ever, gold particles were found at the tips of the gap-
junctional plaques (unpublished data). These results con-
firm that only the two Cx43 epitopes (amino acids 100-122
and 360-382), predicted to be exposed along the cytoplas-
mic surface, are accessible for antibody binding in struc-
turally intact gap junctions. In such preparations, the
protease-protected second extracellular loop (amino acids
186-206) is inaccessible, except possibly at the broken
ends of the plaques.
Labeling of extracellular loops only under specific con-
ditions. Neonatal cardiac myocytes can effectively be
isolated and grown in culture (Mark and Strasser, 1966;
Burt, 1982; Yancey et al. 1989) and can couple through gap
junctions to adjacent cells (Burt and Spray, 1988; Yancey
et al. 1989). Thus, primary cultures of neonatal cardiac
myocytes were employed in an attempt to label Cx43 in
gap junctions using antibodies directed towards the extra-
cellular loops. Conventional methods of permeabilizing
cell pairs with ethanol prior to labeling with the EL-46
antibody were unsuccessful (Fig. 4A). When myocytes
were fixed with paraformaldehyde (but not permeabilized)
and labeled with the EL-46 antibody, small fluorescent
spots were occasionally found dispersed on the cell surface,
but no labeling could be found at the cell boundaries
(Fig. 4B). Similar results were found when ethanol-
treated or paraformaldehyde-fixed cells were stained with
the EL-186 antibody (unpublished data). However, after
treatment with urea at high pH, the EL-46 (Fig. 4C) and
EL-186 (Fig. 4D) antibodies both label junctional plaques
at locations of myocyte cell-cell contact. It appears that in
the alkali/urea-treated myocyte pairs the apposed mem-
branes in gap junctions were split, allowing the EL-46 and
EL-186 antibodies to access the extracellular domains.
The fact that the CT-360 antibody also labels punctate
structures at points of cell-cell apposition in alkali/urea-
treated myocytes (unpublished data) supports the con-
clusion that the EL-46 and EL-186 antibodies are reacting
specifically with Cx43-containing gap junction plaques.
Only myocytes expressed the Cx43 protein
Immunofluorescent labeling studies were performed to
test for the distribution of Cx43 protein in cardiac myocyte
cultures. Labeling of three-day-old cultured cardiac cells
with CT-360 antibody clearly demonstrated the presence
of punctate zones of fluorescence at locations of myocyte
cell-cell contacts (Fig. 5C). In double-labeling exper-
iments the same cells were labeled with an anti-myosin
monoclonal antibody that stained the myofibrils of the
cardiac myocytes but did not label the fibroblasts present
in the culture (Fig. 5B). It is clear that Cx43-containing
junctions are formed between adjacent myocytes but not
generally between myocytes and fibroblasts. However, in a
few cases, we have obtained Cx43 staining at sites of
myocyte-fibroblast apposition (unpublished data). Fibro-
blasts that were in contact with adjacent fibroblasts did
not stain with the CT-360 antibody.
The same structures are labeled by different anti-Cx43
antibodies
In other double-labeling studies, gap junctions were first
labeled with an antibody (CL-100) against the cytoplasmic
loop and then with a second antibody (CT-360) against the
carboxy terminus (Fig. 6). The immunofluorescent labels
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Fig. 3. Transmission electron micrographs of isolated gap junction membranes immunogold labeled after exposure to anti-Cx43 site-
directed antibodies. Immobilized gap junction membranes were treated with CT-360 (A) or CL-100 (B) antibodies followed by goat
anti-rabbit IgG conjugated to 5 run gold particles. Both of these antibodies intensely labeled the cytoplasmic surface of the isolated
gap junction plaques. Ldttle labeling was found when a preimmune serum was used as the primary antibody (C). When EL-186
antibody was used only a few gold particles were found associated with junctional plaques (D). Bar, 0.1/an.
were found to colocalize, irrespective of whether the cells
were permeabilized with ethanol or paraformaldehyde/
Triton X-100 (Fig. 6).
Both phosphorylated and dephosphorylated forms of Cx43
are recognized by CT-360 antibody
Since the CT-360 antibody was raised against a serine-
rich, nonphosphorylated, synthetic peptide, the possibility
existed that the CT-360 antibody only recognized the
nonphosphorylated form of Cx43. In order to test this
possibility, isolated cardiac gap junctions were digested
with alkaline phosphatase before probing with the CT-360
antibody (Fig. 7). In untreated gap junctions a broad
Coomassie Blue-Staining band was found at 43xlO3Mr(Fig. 7, CB lane a); however, after alkaline phosphatase
treatment of the junctions the major band decreased in size
to 40x 103 MT (Fig. 7, CB lane b). The faint but sharp band
at 43xl033fr that remained after alkaline phosphatase
treatment (Fig. 7, CB lane b) was determined by immuno-
blotting to be actin (unpublished data). Alkaline phospha-
tase digestion had no effect on the migration of the three
major breakdown fragments of Cx43 at 35, 33 and
31xlO3Afr (Fig. 7, CB, compare lanes a and b). Immuno-
labeling with the CT-360 antibody resulted in a broad
spectrum of bands from 40-45(xl03)Mr to stain in the
undigested preparation of gap junctions (Fig. 7, CT lane
a). However, the CT-360 antibody bound principally to the
major band at 40xl03Mr in the alkaline phosphatase-
treated sample and failed to bind to the sharp band at
43xl033fr (Fig. 7, CT lane b). Faint CT-360 antibody
binding to the presumed dimer of Cx43 was observed in
both the untreated and alkaline phosphatase-treated
membranes. The 40xl03Mr band produced by alkaline
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Fig. 7. The effect of alkaline phosphatase digestion of gap
junctions on CT-360 antibody binding. Undigested gap junction
membranes (lane a) or alkaline phosphatase-digested gap
junction membranes (lane b) were electrophoresed on a 10 %
SDS-polyacrylamide gel containing 0.4 % bisacrylamide and
either stained with Coomassie Blue (CB) or transferred to
nitrocellulose paper. The Western blot was labeled with the CT-
360 antibody.
phosphatase digestion was not the result of proteolysis at
the amino terminus of Cx43, as this domain was found to
be immunologically intact (unpublished data). These
results clearly indicated that the CT-360 antibody recog-
nized many phosphorylated and dephosphorylated forms
of the Cx43 protein.
Discussion
Topology of Cx43
We have extended the understanding of the structure and
organization of the Cx43 gap junction protein by using
several new site-directed antibodies. We have found that,
in agreement with expectations based on the topology of
the Cx43 protein in gap junction membranes deduced from
previous work, antibody binding to the two potential
extracellular loops was not eliminated after digestion with
several proteolytic enzymes (trypsin, endoproteinase Lys-
C and endogenous proteases). This is believed to be due to
the inability of proteases to penetrate the narrow extra-
cellular gap between apposed membranes in gap junctions.
Support for the structural intactness of gap junctions
under these conditions was provided by studies of
Manjunath et al. (1985) in which gap junctions that were
subjected to proteolysis by endogenous proteases main-
tained their double-membrane appearance. We show here
that when isolated gap junctions are digested with endo-
proteinase Lys-C, the EL-46 antibody bound to a
15xlO3Mr membrane-protected fragment while the EL-
186 antibody labeled a slightly larger fragment of
21xlO3Mr. This is consistent with the EL-46 antibody
recognizing an epitope within the domain that encom-
passes the first and second proposed transmembrane
helices and the EL-186 antibody binding to an epitope
within the membrane-protected segment containing the
third and fourth helices. The failure to label intact junc-
tional membranes with the EL-186 antibody is again
consistent with the 186-206 amino acid segment being
masked within the extracellular gap. In several cases the
tips of the junctional plaques were labeled, suggesting
that, as might have been predicted, extracellular domains
could be exposed in such areas.
Immunogold-labeling studies using the CL-100 and CT-
360 antibodies have demonstrated that the 100-122 and
360-382 amino acid segments are available on the cyto-
plasmic surface of the membrane for antibody binding. In
addition, these two antibodies can be colocalized to the
same junctional plaques. The epitope for CL-100 antibody
binding was lost after trypsin treatment (unpublished
data) but was partially retained after endoproteinase Lys-
C digestion. Therefore, one or more tryptic sites must be
located within or near the 100-122 segment and a major
site of endoproteinase Lys-C digestion probably lies be-
yond the CL-100 antibody binding site. All proteolytic
digestions of Cx43 removed the CT-360 antibody binding
site, confirming the susceptibility of the carboxy terminus
to proteases, as proposed by other investigators (Manju-
nath etal. 19846; Manjunath et al. 1985; Yancey et al.
1989). These results clearly support the idea that the Cx43
polypeptide threads through the membrane four times
yielding accessible proteolytic sites within the cytoplasmic
loop domain and along the carboxy terminus. The reac-
tivity of the anti-peptide antibodies also puts clear con-
straints on the portions of the polypeptide chain that are
protected by the membrane itself.
Cx43 is phosphorylated
It is interesting to note that all the Cx43 site-directed
antibodies label a broad spectrum of bands (within the
range of 40-45 x 103 Mr) on Western blots of gap junction
membranes. In previous reports (Manjunath et al. 19846;
Yancey et al. 1989), speculations were made that the
multiplicity of bands reflected proteolysis at the very
carboxy-terminal tip of the polypeptide. However, we show
here that the CT-360 antibody, raised against the carboxy-
terminal tip (360-382) of Cx43, binds to this wide spec-
trum of bands, thus excluding the possibility of significant
proteolysis within this carboxy-terminal domain. It is
possible that the CT-360 antibody and other site-directed
antibodies, cross-react with a protein highly homologous
to Cx43. At present there is no direct evidence for the
existence of such a protein. An alternate view is that the
Cx43 protein in gap-junctional plaques has undergone
varying degrees of post-translational modifications (i.e.
phosphorylation).
We present evidence that indicates that the CT-360
antibody does in fact recognize a variety of phosphorylated
forms of the Cx43 protein within the 40-45x10 Mr range.
Moreover, there was no migrational change in the major
breakdown fragments at 35, 33 and 31xlO3Mr when
digested with alkaline phosphatase, suggesting that the
carboxy-terminal 8x 103 MT fragment contains most, or all,
of the sites of phosphorylation. These breakdown products
have lost the epitope for binding the CT-360 antibody but
not the segments required for EL-46, CL-100 and EL-186
binding. Whether the carboxy tip is the only site that is
phosphorylated is uncertain. It is possible that the large
breakdown fragments are phosphorylated at sites that are
inaccessible to the alkaline phosphatase. In addition, it is
not clear how many phosphate residues need to be
removed to make a cleavage resolvable by SDS-PAGE. On
the basis of the primary sequence of Cx43, the 360-382
segment alone contains six serine residues (Beyer et al.
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1987). Four of these serine residues are positionally
identical to carboxy-terminal serine residues in a lens
fiber Cx46 protein (Beyer et al. 1988). Exact conservation
of these residues is consistent with the idea that these
serine residues may be important in regulating junctional
activity. Interestingly, within the last 20 amino acid
residues of the Cx43 sequence there are three consensus
sites for possible calmodulin-dependent phosphorylation
(Miller et al. 1988). These potential phosphorylation sites
are not found in the liver Cx26 and Cx32 gap junction
proteins. However, previous studies have shown that in
the liver the catalytic subunit of cyclic AMP-dependent
protein kinase is directly involved in the phosphorylation
of a serine residue on Cx32 gap junction protein and in the
modulation of channel conductance (Spray et al. 1985;
Saez et al. 1986), but the mechanism or role of phosphoryl-
ation in Cx43 is not known at present.
Heterologous junctions
Gap-junctional plaques were clearly labeled with CL-100
and CT-360 antibodies at areas of cell-cell contact in
neonatal myocyte cell cultures. Sometimes, but not
always, immunofluorescently labeled plaques were ob-
served at locations of myocyte-fibroblast apposition
(unpublished data). This is reminiscent of recent work by
Rook et al. (1989), who have identified not only electrically
coupled myocytes but also myocytes that were coupled to
fibroblasts. These heterologous gap junction channels
were believed to be composed of two different connexins
that possess homologous extracellular domains. Our re-
sults suggest that in some cases myocytes may contribute
Cx43 in the form of hemichannels for gap junction forma-
tion with fibroblasts.
Is all Cx43 in plaques?
In neonatal cardiac myocyte cultures the presence of Cx43
on the cell surface was occasionally detected by the EL-186
and EL-46 antibodies in immunofluorescent labeling
studies. It is possible that such labeling detects partially
assembled gap junction membrane structures that are
remnants from the cardiac tissue prior to culturing. It has
also been claimed that gap junction degradation and
disappearance in cultured adult cardiac myocytes is a slow
process (Severs etal. 1989). Alternatively, Cx43 protein
located on the cell surface of neonatal myocytes may
represent partially assembled junctional plaques that are
in the process of being sorted as hemichannels to locations
of cell-cell contact for the complete channel formation.
Assembled gap junctions do not react with the EL-46 or
EL-186 antibodies unless the myocyte junctions are dis-
rupted (split) with an alkali/urea treatment. Alkali/urea
treatments of gap junctions have been reported to break
hydrogen and hydrophilic bonds between connexons,
resulting in the formation of single membrane struct-
ures (Manjunath etal. 1984a,6; Zimmer etal. 1987;
Goodenough et al. 1988).
In summary, five site-directed antibodies have been
raised against strategically chosen domains of the Cx43
protein. These antibodies have been used to confirm the
proposed model of Cx43 where the polypeptide chain
threads through the membrane four times, yielding two
extracellular loops and a protease-sensitive cytoplasmic
loop. These antibodies should prove to be useful immuno-
logical probes in studying the assembly and disassembly of
gap junctions in cardiac tissue. In addition, as the empha-
sis of Cx43 studies moves towards a more analytical
dissection of protein function, these antibodies may prove
to be extremely valuable tools for studying native and
mutated Cx43 protein in expression systems.
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